120 related articles for article (PubMed ID: 6286399)
21. Lytic infection of teratocarcinoma cells by polyoma virus mutants.
Vasseur M; Kress C; Montreau N; Blangy D
Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():301-4. PubMed ID: 6253144
[No Abstract] [Full Text] [Related]
22. Analysis of transcription factors binding to the duplicated PEA1 and PEA3 sites that are required for polyomavirus mutant expression in PCC4 embryonic carcinoma cells.
Nothias JY; Weinmann R; Blangy D; Melin F
J Virol; 1993 Jun; 67(6):3036-47. PubMed ID: 8388487
[TBL] [Abstract][Full Text] [Related]
23. Physical and biological features of polyoma virus mutants able to infect embryonal carcinoma cell lines.
Vasseur M; Katinka M; Herbomel P; Yaniv M; Blangy D
J Virol; 1982 Sep; 43(3):800-8. PubMed ID: 6292462
[TBL] [Abstract][Full Text] [Related]
24. Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells.
Fujimura FK; Deininger PL; Friedmann T; Linney E
Cell; 1981 Mar; 23(3):809-14. PubMed ID: 6261957
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of mouse mutant embryonal carcinoma cells which fail to differentiate in response to retinoic acid.
Schindler J; Matthaei KI; Sherman MI
Proc Natl Acad Sci U S A; 1981 Feb; 78(2):1077-80. PubMed ID: 6940125
[TBL] [Abstract][Full Text] [Related]
26. In vitro differentiation of mouse teratocarcinoma cells monitored by intermediate filament expression.
Paulin D; Jakob H; Jacob F; Weber K; Osborn M
Differentiation; 1982; 22(2):90-9. PubMed ID: 6182048
[TBL] [Abstract][Full Text] [Related]
27. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.
Kryszke MH; Piette J; Yaniv M
Nature; 1987 Jul 16-22; 328(6127):254-6. PubMed ID: 3037385
[TBL] [Abstract][Full Text] [Related]
28. Competition studies with repressors and activators of viral enhancer function in F9 mouse embryonal carcinoma cells.
Sleigh MJ; Lockett TJ; Kelly J; Lewy D
Nucleic Acids Res; 1987 May; 15(10):4307-24. PubMed ID: 3035489
[TBL] [Abstract][Full Text] [Related]
29. Complementation analyses of differentiation-defective embryonal carcinoma cells.
McCue PA; Gubler ML; Maffei L; Sherman MI
Dev Biol; 1984 Jun; 103(2):399-408. PubMed ID: 6144604
[TBL] [Abstract][Full Text] [Related]
30. Differentiation-defective mutants of mouse embryonal carcinoma cells: response to hexamethylenebisacetamide and retinoic acid.
McCue PA; Matthaei KI; Taketo M; Sherman MI
Dev Biol; 1983 Apr; 96(2):416-26. PubMed ID: 6299821
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus infection of human teratocarcinoma cells in culture.
Gönczöl E; Andrews PW; Plotkin SA
J Gen Virol; 1985 Mar; 66 ( Pt 3)():509-15. PubMed ID: 2982999
[TBL] [Abstract][Full Text] [Related]
32. Cell lines derived from teratocarcinomas.
Nicolas JF; Avner P; Gaillard J; Guenet JL; Jakob H; Jacob F
Cancer Res; 1976 Nov; 36(11 Pt. 2):4224-31. PubMed ID: 61803
[TBL] [Abstract][Full Text] [Related]
33. Further characterization of the interaction of polyoma virus and simian virus 40 with embryonal carcinoma cells.
Hales K; Lehman JM
Exp Mol Pathol; 1987 Aug; 47(1):48-58. PubMed ID: 3038593
[TBL] [Abstract][Full Text] [Related]
34. The nature of the host range restriction of SV40 and polyoma viruses in embryonal carcinoma cells.
Levine AJ
Curr Top Microbiol Immunol; 1982; 101():1-30. PubMed ID: 6303700
[No Abstract] [Full Text] [Related]
35. The state of simian virus 40 DNA in the embryonal carcinoma cells of the murine teratocarcinoma.
Friedrich TD; Lehman JM
Virology; 1981 Apr; 110(1):159-66. PubMed ID: 6259827
[No Abstract] [Full Text] [Related]
36. Cellular HSP90 (HSP86) mRNA level and in vitro differentiation of mouse embryonal carcinoma (F9) cells.
Kohda T; Kondo K; Oishi M
FEBS Lett; 1991 Sep; 290(1-2):107-10. PubMed ID: 1655528
[TBL] [Abstract][Full Text] [Related]
37. Establishment of composite DNA derived from L factor as a plasmid in mouse embryonal carcinoma (F9) cells.
Nishimori K; Kohda T; Fujiwara J; Oishi M
Mol Cell Biol; 1988 May; 8(5):2097-104. PubMed ID: 2838742
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of polyoma host range mutants that replicate in nullipotential embryonal carcinoma cells.
Sekikawa K; Levine AJ
Proc Natl Acad Sci U S A; 1981 Feb; 78(2):1100-4. PubMed ID: 6262755
[TBL] [Abstract][Full Text] [Related]
39. Expression of polyoma virus in heterokaryons between embryonal carcinoma cells and differentiated cells.
Boccara M; Kelly F
Virology; 1978 Oct; 90(1):147-50. PubMed ID: 213890
[No Abstract] [Full Text] [Related]
40. Regulation of the cellular retinoid-binding proteins and their messenger ribonucleic acids during P19 embryonal carcinoma cell differentiation induced by retinoic acid.
Wei LN; Blaner WS; Goodman DS; Nguyen-Huu MC
Mol Endocrinol; 1989 Mar; 3(3):454-63. PubMed ID: 2546063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
